Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $17.9 million.

  • Neuronetics' Cash from Financing Activities changed N/A to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.4 million, marking a year-over-year change of. This contributed to the annual value of -$6.8 million for FY2024, which is 12999.52% down from last year.
  • Per Neuronetics' latest filing, its Cash from Financing Activities stood at $17.9 million for Q3 2025.
  • Neuronetics' 5-year Cash from Financing Activities high stood at $82.2 million for Q1 2021, and its period low was -$62000.0 during Q2 2023.
  • For the 5-year period, Neuronetics' Cash from Financing Activities averaged around $10.9 million, with its median value being $372000.0 (2022).
  • Over the last 5 years, Neuronetics' Cash from Financing Activities had its largest YoY gain of 898571.43% in 2023, and its largest YoY loss of 72000.0% in 2023.
  • Over the past 5 years, Neuronetics' Cash from Financing Activities (Quarter) stood at $32000.0 in 2021, then soared by 665.62% to $245000.0 in 2022, then soared by 8985.71% to $22.3 million in 2023, then crashed by 57.04% to $9.6 million in 2024, then soared by 87.17% to $17.9 million in 2025.
  • Its Cash from Financing Activities was $17.9 million in Q3 2025, compared to $1000.0 in Q2 2025 and $19.0 million in Q1 2025.